Evaluation of the effect of an Ayurvedic Dietary Formulation (Panchakolasiddha yavagu) in reducing the Disease Activity Score (DAS28 using C‐reactive protein) among Amavata patients
Background and objectives: Amavata, is one among the multiple joint disorders explained in Ayurvedic classics. Its pathology is explained to be beginning with the sluggish functioning of the bio fire (agni) or the digestive capacity. The disease is having high prevalence rate and is of crippling nature. Practically there is no effective proven intervention in popular practice to break the chains in the pathogenesis by correcting the bio-fire. Hence it was a high time to develop such an intervention with a therapeutic diet restricting all other medicine and food to check the pathogenesis and thereby the disease activity.
Aim: The study attempted to evaluate effect of an Ayurvedic dietary formulation, Panchakolasiddha yavagu in reducing the disease activity by using the Disease Activity Score (DAS 28) using CRP, among amavata patients.
Settings and Design: Vaidyaratnam P S Varier Ayurveda College, Kottakkal, Open clinical trial
Methods: 20 participants were selected. Intervention was till the attainment of proper digestive capacity, the optimum functioning of bio fire or maximum up to 10 days. Panchakolasiddha yavagu prepared as per the classical reference was given in morning and evening restricting all other food and medicine. Pain was assessed daily using Numerical Rating Scale. Disease activity score was used to assess the symptomatic relief.
Statistical analysis used: Paired t test was used to assess effect of intervention. Statistical analysis was done by using Microsoft Office 2007 Excel, Graphpad InStat version 3, and IBM SPSS Statistics version 16.
Results: There was highly significant reduction in pain (p<0.001), significant reduction in disease activity (p<0.001). The intervention shows significant results in reducing the CRP levels (p<0.05).
Conclusion: Administration of the Ayurvedic dietary preparation, panchakolasiddha yavagu was highly effective in reducing the disease activity score DAS28. It was highly effective in reducing the pain and maximum significant change is observed between day 7 and day 8. It also helped to reduce the CRP levels significantly.
The author(s) will retain copyright and permit the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that permits others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
The entire contents of the JAHM are protected under Indian and international copyrights. The Journal, however, allows free, irrevocable, worldwide, perpetual right of access to, and a license to copy, use, distribute, perform and display the work publicly and to make and distribute derivative works in any digital medium for any reasonable non-commercial purpose, subject to proper attribution of authorship and ownership of the rights. The journal also permits the right to make small numbers of printed copies for their personal non-commercial use under Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported License.
In case of JAHM does not publish said work, the author(s) will be so notified and all rights assigned hereunder will be given back to the author(s).
All accepted works should not be published anywhere without prior written permission from JAHM. The author(s) hereby declare that they are sole author(s) of the work, that all authors have contributed and agree with the content and conclusions of the work, that the work is original, and does not infringe upon any copyright, propriety, or personal right of any third party, and that no part of it nor any work has been submitted to another journal.